The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation• Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?• Breathing Engineered Bacteria: A New Approach to Treating Lung Disease• Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data• Gut fungi may hold the key to treating Asthma worldwide•

Category: Regulatory & Policy

DNA Genotek enables development of microbiome-based clinical applications with OMNIgene™•GUT Dx – the first and only FDA-authorized fecal self-collection device
Basic & Discovery Research

DNA Genotek enables development of microbiome-based clinical applications with OMNIgene™•GUT Dx – the first and only FDA-authorized fecal self-collection device

MAY 10, 2023
Recipharm will manufacture VOWST on behalf of Seres Therapeutics
Finance

Recipharm will manufacture VOWST on behalf of Seres Therapeutics

MAY 2, 2023
FDA Lifts Hold on Maat Pharma’s Phase 3 Investigational NDA for MaaT013
Clinical & Manufacturing

FDA Lifts Hold on Maat Pharma’s Phase 3 Investigational NDA for MaaT013

APR 28, 2023
Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWST™
Editor's Choice

Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWST™

APR 27, 2023
Regulatory pathway needs to be developed to make the most of phages
Pharma & Human Health

Regulatory pathway needs to be developed to make the most of phages

FEB 16, 2023
Micronoma receives FDA breakthrough device designation for novel liquid biopsy assay for lung carcinoma detection
Oncology & Cancer

Micronoma receives FDA breakthrough device designation for novel liquid biopsy assay for lung carcinoma detection

JAN 12, 2023
FDA Approves First Fecal Microbiota Product
Editor's Choice

FDA Approves First Fecal Microbiota Product

DEC 1, 2022
Proge Farm claims Europe’s first regulatory approval for a microbiome-based therapeutic
Editor's Choice

Proge Farm claims Europe’s first regulatory approval for a microbiome-based therapeutic

NOV 29, 2022
BiomeBank announces regulatory approval for donor derived microbiome drug
Finance

BiomeBank announces regulatory approval for donor derived microbiome drug

NOV 9, 2022
Seres Therapeutics Announces FDA acceptance of Biologics License Application For Ser-109
Editor's Choice

Seres Therapeutics Announces FDA acceptance of Biologics License Application For Ser-109

OCT 28, 2022
The Complexities of Regulatory Approval for Live Biotherapeutic Products Unravelled
Finance

The Complexities of Regulatory Approval for Live Biotherapeutic Products Unravelled

OCT 19, 2022